76 studies found for:    Cushing's Syndrome | Exclude Unknown
Show Display Options
Rank Status Study
1 Terminated A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Condition: Cushing's Syndrome
Intervention: Drug: Cushing's syndrome confirmation
2 Recruiting Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
Conditions: Cushing's Syndrome;   Adrenal Incidentalomas;   Alcoholism;   Obesity
3 Terminated
Has Results
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Intervention: Drug: Mifepristone
4 Completed
Has Results
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
5 Recruiting Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Conditions: Cushing's Syndrome,;   Ectopic Corticotropin Syndrome,;   Adrenal Adenoma,;   Adrenal Carcinoma,;   AIMAH,;   PPNAD
Intervention: Drug: Osilodrostat
6 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Interventions: Procedure: Adrenalectomy;   Other: Observation
7 Completed
Has Results
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Conditions: Cushing's Disease;   Cushing's Syndrome
Intervention: Drug: Mifepristone
8 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)
9 Completed
Has Results
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
10 Recruiting Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
Condition: Cushing Syndrome
Intervention: Procedure: surgery
11 Completed Long Term Post Operative Follow-Up of Cushing Syndrome
Condition: Cushing Syndrome
12 Completed Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Condition: Cushing's Syndrome
13 Not yet recruiting Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
Condition: Cushing's Syndrome Cardiomyopathy
Intervention: Drug: Tadalafil
14 Recruiting Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
Condition: Pituitary Adenoma
Intervention: Device: continuous glucose monitoring
15 Recruiting Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
16 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003
17 Recruiting Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
Conditions: Cushing's Syndrome;   Insulin Resistance
Intervention: Procedure: Surgery
18 Recruiting Cardiac Steatosis in Cushing's Syndrome
Conditions: Endocrine System Disease;   Cardiovascular Imaging
Intervention: Other: 1H magnetic resonance spectroscopy and CMRI
19 Recruiting Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
20 Recruiting Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors
Condition: Cushing Syndrome
Intervention: Radiation: Adrenal venous sampling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years